[Facial paralysis during anticoagulant treatment].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy; D048909:Diabetes Complications; D005158:Facial Paralysis / Q000139:chemically induced* / Q000150:complications / Q000188:drug therapy; D006406:Hematoma / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000150:complications; D010159:Palate; D010306:Parotid Gland; D010630:Phenindione / Q000009:adverse effects*; D012466:Salivary Gland Diseases / Q000150:complications; D014812:Vitamin K / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014812:Vitamin K; D010630:Phenindione
Paralysie faciale au cours d'un traitement anticoagulant.